(Date:11/6/2009)..., Statement by James P. Firman, President and CE...ON, Nov. 6 The National...rdable Health Care for America Act (H.R. 3962), wh...ial goal of accessible, quality health care for Am...sis, we have concluded that the bill is a good dea...
(Date:11/6/2009)..., PHILADELPHIA, Nov. 6 The Ameri...s and editorial board members of Lippincott Willia...demy Fellows. LWW is part of Wolters Kluwer Health...ntelligence for students, professionals, and insti...harmacy. Academy Fellows are selected based on evi...
(Date:11/6/2009)...rsing exclusively for six months, then with foods ..., , FRIDAY, Nov. 6 (HealthDay News) -- B...nd mothers, and should be promoted and encouraged,...erican Dietetic Association. , "It is the posit...usive breast-feeding provides optimal nutrition an...
(Date:11/6/2009)...posed infants more susceptible to bronchiolitis, s... News) -- That picturesque wood-burning stove rank...chiolitis, the respiratory condition that is the l...of life, a new study finds. , "Those infants wh...e more likely to show up in doctors, offices or be...
(Date:11/6/2009)...(PHILADELPHIA) A rapid decline in metabolic activi...mall cell lung cancer is correlated with good loca... researchers at Thomas Jefferson University Hospit...on, the researchers also found that the higher the...efore treatment, the more likely a patient is to d...
Breaking Medicine News(10 mins):Health News:NCOA Supports H.R. 3962, the Affordable Health Care for America Act 2Health News:Seven LWW Nursing Editors Recognized as Leaders by American Academy of Nursing 2Health News:Seven LWW Nursing Editors Recognized as Leaders by American Academy of Nursing 3Health News:Breast-Feeding Benefits Moms and Babies: Report 2Health News:Wood Fires Can Harm the Youngest Lungs 2... limits of human physiology than the Olympics" To ...siology present a special issue focusing on the sc...his unique collection of original research and in-...ss body heat is a barrier to performance in many s...
...(Nasdaq:,HMSY) today announced that it will presen...e, which will be held January 7-10, 2008 at the We...//www.newscom.com/cgi-bin/prnh/20030304/NYTU172LOG...he Company,s presentation can be accessed through,...
...ng depression improves health of ...Studies show that people with heart,disease are mo...hout heart,disease. The link between these two dis...s why researchers from the University of Michigan ...
...dy found , THURSDAY, Dec. 20 (HealthDay News) -- E...oost a child,s risk of developing allergies, Swedi...titute, Stockholm, analyzed questionnaires filled ...rs and 4 years. In addition, the researchers colle...
...ock Exchange Symbol: AKL, MONTREAL, Dec. 20 /PRNe..., a drug development company focused on developing...day announced that due to unfavorable market,condi...ting other financing options. It is still the Comp...
...pdated their Food Guide Pyramid for Older Adults t... as MyPyramid. The Tufts version is specifically d...ance and content. The Modified MyPyramid for Older... that could best meet the unique needs of older ad...
Other Medicine News:Health News:Blue Cross Blue Shield of Michigan Foundation Funds Study Exploring Link between Heart Disease and Depression 2Health News:Parents' Smoking Boosts Child's Allergy Risk 2Health News:Akela Pharma provides corporate update 2Health News:Tufts researchers update their food guide pyramid for older adults 2Health News:Tufts researchers update their food guide pyramid for older adults 3(Date:11/6/2009)...swire-FirstCall/ -- Caraco Pharmaceutical Laborato...ac tromethamine ophthalmic solution, 0.5% followin...istration (FDA) for Sun Pharma,s Abbreviated New D...thalmic solution on the first day following patent...utically equivalent to Acular® Ophthalmic Sol...
(Date:11/6/2009)... , - Trial Will Compare NX...atment of Multi-Resistant Staphylococcus Aureus (M...harmaceutical company focused on the discovery and...come the significant global,problem of microbial r...oral,antibacterial NXL103 (flopristin/linopristin)...
(Date:11/5/2009)...Newswire/ -- Althea Technologies, Inc., a leading ... for biopharmaceutical products announced the addi...company,s platform of services, which will be over...rector of Formulation Development. This investment...cal scientists, along with new laboratory faciliti...
Breaking Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services 2A Unique Rhythm In The Heart Of Coconut Grove Florida 51034 1A Unique Rhythm In The Heart Of Coconut Grove Florida 51034 2Cellular Dynamics International Reprograms Blood Cells into Stem Cells 12932 1Cellular Dynamics International Reprograms Blood Cells into Stem Cells 12932 2Concierge Medicine Takes Front Seat with Health Care Reform Uncertainty 51029 1Concierge Medicine Takes Front Seat with Health Care Reform Uncertainty 51029 2...g. 21 Johnson & Johnson Pharmaceutical,Research &... the U.S. Food,and Drug Administration (FDA) requi...the company,s New Drug Application (NDA) for DORIB... of hospital-acquired pneumonia,also known as noso...ated,pneumonia (VAP)., In response to the J&JPRD ...
... Enobia Pharma, an emerging biotech,company focus...ne,disorders, today announced that the first patie...s been dosed. Enobia is investigating Enzyme,Repla...nt of this rare and,often crippling genetic bone d... Under two separate protocols, ENB-0040 will be e...
Other Medicine Technology:FDA Requires Additional Information on DORIBAX for Treatment of Hospital-Acquired Pneumonia 2FDA Requires Additional Information on DORIBAX for Treatment of Hospital-Acquired Pneumonia 3FDA Requires Additional Information on DORIBAX for Treatment of Hospital-Acquired Pneumonia 4FDA Requires Additional Information on DORIBAX for Treatment of Hospital-Acquired Pneumonia 5Enobia Pharma Initiates Clinical Testing of Enzyme Replacement Therapy to Treat Hypophosphatasia 2Enobia Pharma Initiates Clinical Testing of Enzyme Replacement Therapy to Treat Hypophosphatasia 3CritiCool
MONOJECT Yellow Stopper
BD Vacutainer® Specialty Tubes - Sodium Polyanetholesulfonate (SPS)
BD Vacutainer® Specialty Tubes - Other - Glass
Medicine Products: